Excess fatness is frequent after childhood ALL treated without BMT. We measured the whole-body percent fat by dual-energy X-ray absorptiometry and the bodymass index (weight/height 2 (kg/m 2 ), BMI) in 25 survivors of childhood leukaemia or lymphoma (21 with ALL) who had received TBI and allogeneic BMT a median of 8 years ago (range 4-13). Adjusted for sex and age, the mean BMI was slightly but significantly reduced (0.4 s.d. below predicted) and the whole-body percent fat was significantly increased compared with healthy controls (1.1 s.d. above predicted). Eleven of 25 patients had a percent fat above the 90 percentile of the reference values, which indicates excess fatness. Adjusted for sex and age, a higher percent fat was related to additional cranial irradiation. Controlled for this, the whole-body percent fat seemed to be unrelated to age at BMT, length of follow-up, and previous chemotherapy. Compared with untransplanted ALL survivors treated with cranial irradiation, BMT survivors had significantly reduced BMI but similar whole body percent fat. BMI was a poor measure of body fatness in these patients. In conclusion, survivors of BMT for childhood leukaemia or lymphoma are adipose and slightly underweight and consequently have a substantially reduced lean body mass. Bone Marrow Transplantation (2001) 27, 817-820. Keywords: leukaemia; lymphoma; childhood; late sideeffects of therapy; body-mass index; body composition During the last decades the survival rates after childhood leukaemia and lymphoma have risen considerably.
During the last decades the survival rates after childhood leukaemia and lymphoma have risen considerably. 1 For children with very high risk 2 or relapsed disease, [3] [4] [5] allogeneic BMT with a related donor will give the highest chance of survival. Unfortunately, allogeneic BMT for childhood cancer has frequent and severe delayed side-effects.
Body-mass index (weight/height 2 (kg/m 2 ), BMI) is considered the best available weight-stature index in both chil- dren and adults, regarding independence of stature, correlation with body fat, and prediction of mortality. 6 Raised BMI (overweight) in childhood and adolescence increases the risk of being overweight in adulthood, 7, 8 and overweight in adolescence 9 and adulthood 10, 11 is associated with excess morbidity and mortality. In industrialised countries, the frequency of overweight people has increased over the last decades. 12 Whole-body dual-energy X-ray absorptiometry (DXA) is currently considered the most valid practically usable method for non-invasively measuring the body composition according to a three-compartment model based on bone mineral mass, fat mass, and non-fat non-mineral mass. 13, 14 Impaired growth hormone secretion is frequent after cranial or total body irradiation for childhood cancer. 15, 16 Growth hormone deficient children 17 and adults 18 are adipose, also when matched for BMI. Consequently, BMI is a less valid measure of adiposity in survivors of childhood cancer than in the background population. The BMI [19] [20] [21] [22] [23] [24] [25] and the degree of fatness [25] [26] [27] after childhood ALL treated without BMT have been frequently reported, but only one group has reported the BMI after childhood BMT. 28 Whereas excess fatness and, sometimes, being overweight are problems in ALL survivors treated without BMT, childhood BMT survivors seem to suffer mainly from malnutrition and being underweight, at least during the first years following transplantation.
We have studied the BMI and the whole-body percent fat of 25 persons several years after allogeneic BMT for childhood leukaemia or lymphoma. Results were compared with data from 463 healthy local controls and from 95 childhood ALL survivors in CR1 treated without BMT.
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Patients and methods
Patients
Before 31 December 1990, 43 patients had been treated with allogeneic BMT including TBI for haematological malignancies diagnosed before the age of 15 while they resided in East Denmark. Twenty-five (86%) of the 29 patients who were alive in January 1992 (survival 67%) were studied a median of 8 years after BMT (range 4-13). Twenty-one had ALL, two AML, one CML, and one T cell non-Hodgkin's lymphoma. Seventeen participants were transplanted in CR2. None of the participants had chronic GVHD, whereas three of four non-participants had severe chronic GVHD. Details on the study participants and the methods have been published by us previously. 25 32 and international cut-off values for children 33 and adults. 34 Whole-body percent fat was determined at follow-up examination by DXA using a Hologic 1000/W (Hologic, Waltham, MA, USA). Whole-body percent fat measurements were compared with local reference values based on data on 463 children, adolescents and young adults examined with the same scanner. 25 To account for the increasing frequency of overweight people in industrialised countries over the last decades, 12 BMI at follow-up was compared with data on the same group and with data on 485 20 to 29 year olds from a population study examined from 1991 to 1994. 35 The GH axis was tested at follow-up as described previously. 30 
Data analysis
Results were analysed as age-and sex-specific z scores using t-tests and single and multiple linear regression analysis. 25 Z scores for BMI and percent fat were calculated with the LMS method of Cole and Green. 25 37 
Ethics
All participants and the parents of the children younger than 18 years gave their written informed consent. The study was in accordance with the Helsinki II declaration and was approved by the local medical ethics committee of Copenhagen and Frederiksberg, Denmark (Approval No. KF V92-097).
Results
Compared to its level prior to diagnosis or BMT, the BMI z score at follow-up tended to be increased in two patients (Nos 9 and 13), reduced in seven patients (Nos 2, 12, 14 (Figure 1 ). According to international BMI cutoff values, 33, 34 one adult woman was overweight and one adult man was obese. No adolescents were overweight. The BMI was significantly higher in 13 patients treated with additional cranial irradiation than in the remaining patients (estimated difference 1.01 z score, CI 0.05 to 1.96, P ϭ 0.04). The BMI was significantly lower in patients treated with allogeneic BMT than in 95 ALL survivors in CR1 treated without BMT (estimated difference 0.66, CI 0.18 to 1.14, P ϭ 0.007), also when adjusted for cranial irradiation (estimated difference 0.70, CI 0.22 to 1.18, P ϭ 0.004) or when compared with the 39 ALL controls treated with cranial irradiation (estimated difference 0.78, CI 0.21 to 1.34, P ϭ 0.008).
The mean whole-body percent fat was significantly increased compared with healthy controls (z ϭ 1.05, CI 0.56 to 1.54, P ϭ 0.0002; observed:predicted value 24.8:19.1%) and 11 patients had a percent fat z score larger * * * (Figure 1) . In regression analysis, higher percent fat was significantly related to having received additional cranial irradiation (estimated difference 1.22 z score, CI 0.36 to 2.07, P ϭ 0.007) and tended to be related to GH insufficiency (estimated difference 0.86, CI Ϫ0.11 to 1.84, P ϭ 0.08). Additional cranial irradiation and GH insufficiency were, however, not both significant in the same model (P ϭ 0.03 and 0.36). Adjusted for additional cranial irradiation, the whole-body percent fat z score was not significantly related to sex, age at BMT, length of follow-up after BMT, age at follow-up, use of dexamethasone, the cumulative dose of dexamethasone, corticosteroids, or anthracyclines, or the cumulative doses of dexamethasone and prednisone (P ϭ 0.48-0.95). The whole-body percent fat of the allogeneic BMT survivors did not differ significantly from that of 39 ALL survivors treated with cranial irradiation but without BMT (estimated difference 0.11 z score, CI Ϫ0.46 to 0.68, P ϭ 0.70). Percent fat and BMI z scores at follow-up were significantly related (R 2 ϭ 0.47, P ϭ 0.0002) but the 95% confidence interval for predicting individual percent fat z scores from BMI were nearly 4 z scores wide (Figure 1 ). For a given BMI, patients treated with additional cranial irradiation tended to have a higher percent fat z score than the remaining patients (estimated difference 0.67, CI Ϫ0.10 to 1.44, P ϭ 0.08).
Discussion
A median of 8 years after TBI and allogeneic BMT for childhood leukaemia or lymphoma, the mean whole-body percent fat was significantly higher than in healthy controls but did not differ significantly from that of 39 childhood ALL survivors treated with cranial irradiation but without BMT.
Compared to its level prior to diagnosis, BMI decreased or remained largely unchanged during follow-up in most of our participants, and the mean BMI at last follow-up was slightly but significantly reduced compared with recently examined local control groups. In the only previous study of BMI several years after BMT, Cohen et al 28 found that the mean BMI of 87 persons transplanted in childhood increased from 17.3 kg/m 2 at BMT to 19.6 kg/m 2 at followup 7 years later. BMI did not change significantly during follow-up in persons transplanted in adulthood. The previous study is limited by lack of BMI data at diagnosis of the malignancy and by analysing BMI values of children without adjusting for sex and age. 38 Several studies have suggested that persons previously treated for ALL without BMT have increased BMI, [19] [20] [21] [22] [23] [24] but recently we reported that they have BMI like local controls. 25 The use of old reference values in the previous studies, random variation, and, maybe, variation in the use and dose of cranial irradiation, probably explain why our BMI findings in untransplanted ALL survivors did not agree fully with those of others.
Despite their normal BMI, ALL survivors treated without BMT had significantly increased whole-body percent fat 25 which was limited to the patients treated with cranial Bone Marrow Transplantation irradiation. Others have suggested that anthracyclines 26, 39 or dexamethasone 22, 40 are associated with excess fatness after childhood ALL treated without BMT, but we could not confirm this. 25 In accordance with this, in the present study, additional cranial irradiation or GH insufficiency, but not anthracycline dose or the use of dexamethasone, were associated with excess fatness after BMT for childhood leukaemia or lymphoma.
The similar levels of whole-body percent fat in BMT survivors and ALL controls treated with cranial irradiation may suggest that cranial irradiation, its sequelae, or associated risk factors such as reduced physical activity are the main causes of the excess fatness seen in both groups. The BMI abnormalities are more complex with normal or slightly increased BMI after ALL treated without BMT but reduced BMI after leukaemia or lymphoma treated with BMT. One could speculate that the tendency to increasing BMI seen in ALL survivors treated without BMT is counteracted in BMT survivors by a tendency to malnutrition, caused either by the TBI or by the more severe delayed side-effects after BMT. As the BMT survivors were slightly underweight and had an increased percent fat, they had a substantially reduced lean body mass.
Our group of participants should be a non-biased sample of survivors of BMT for childhood leukaemia or lymphoma, except that none had chronic GVHD. One participant (patient No. 21) had a partly paretic leg, but when he was excluded from the analysis, conclusions were essentially the same.
In conclusion, 8 years after TBI and allogeneic BMT for childhood leukaemia or lymphoma, the whole-body percent fat was increased, mainly in persons treated with additional cranial irradiation, and the lean body mass was substantially reduced.
